Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: AxCell, Mount Sinai Partner for Nephropathy Research

NEW YORK, April 30 - AxCell Biosciences said today that it will collaborate with Mount Sinai School of Medicine researcher Irwin Gelman to study HIV-assocated nephropathy.


The research seeks to identify new treatments for the disease. It is the second partnership between AxCell and Mount Sinai.


Under the agreement, AxCell will provide its expertise in signal transduction analysis to find molecules that inhibit interactions between cellular proteins and HIV proteins. Lead molecules will be tested in cell culture and with transgenic mice.


The company has an option to negotiate exclusive, worldwide, royalty-bearing licenses from the medical school for any inventions developed in this collaboration.


Incidence of HIV-related nephropathy is on the rise, as patients treated with antiretrovirals live longer.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.